Eiger BioPharmaceuticals CCO Eldon Mayer III Resigns
Market News

Eiger BioPharmaceuticals CCO Eldon Mayer III Resigns

Eiger Biopharmaceuticals (EIGR) has released an update to notify the public and investors about its officers.

Eldon Mayer III has resigned as the Chief Commercial Officer of Eiger BioPharmaceuticals, Inc., with his resignation set to take effect on February 2, 2024. He notified the company of his decision on January 18, 2024.

For further insights into EIGR corporate activity, check out TipRanks’ Insiders Trading Activity page.

Related Articles
TheFlyTwo option delistings on April 12th
TheFlyBiotech Alert: Searches spiking for these stocks today
TipRanks Auto-Generated NewsdeskEiger BioPharmaceuticals: Bankruptcy, Delisting, and Board Resignation
Go Ad-Free with Our App